Follow-up strategies and management of recurrence in urologic oncology bladder cancer: Invasive bladder cancer

被引:47
作者
Bochner, BH
Montie, JE
Lee, CT
机构
[1] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[3] Univ Michigan, Ctr Med, Dept Urol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/S0094-0143(03)00061-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
A surveillance program following cystectomy should consider a patient's individual risk for the development of local and distant recurrences and any specific needs related to the urinary tract reconstruction performed. Well-documented recurrence patterns following cystectomy are available from many large surgical series and provide the background information needed for tailoring follow-up based on pathologic criteria. Economic issues also must be considered, given that the health care-related expenses of treating and following patients with bladder cancer is twice as much as that expended for the treatment of prostate cancer. Because of the ever-increasing fiscal constraints placed on clinicians, risk-adjusted follow-up strategies are reasonable, but will require prospective evaluation to validate their appropriateness.
引用
收藏
页码:777 / +
页数:15
相关论文
共 100 条
[1]
RENAL-FUNCTION AND UPPER URINARY-TRACT CONFIGURATION FOLLOWING URINARY-DIVERSION TO A CONTINENT ILEAL RESERVOIR (KOCK POUCH) - A PROSPECTIVE 5-YEAR TO 11-YEAR FOLLOW-UP AFTER RESERVOIR CONSTRUCTION [J].
AKERLUND, S ;
DELIN, K ;
KOCK, NG ;
LYCKE, G ;
PHILIPSON, BM ;
VOLKMANN, R .
JOURNAL OF UROLOGY, 1989, 142 (04) :964-968
[2]
Ureteroscopic management of patients with upper tract transitional cell carcinoma [J].
Assimos, DG ;
Hall, MC ;
Martin, JH .
UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (04) :751-+
[3]
Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].
Bajorin, DF ;
Dodd, PM ;
Mazumdar, M ;
Fazzari, M ;
McCaffrey, JA ;
Scher, HI ;
Herr, H ;
Higgins, G ;
Boyle, MG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181
[4]
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial [J].
Bajorin, DF ;
McCaffrey, JA ;
Hilton, S ;
Mazumdar, M ;
Kelly, WK ;
Scher, HI ;
Spicer, J ;
Herr, H ;
Higgins, G .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2722-2727
[5]
Upper tract recurrences following radical cystectomy: An analysis of prognostic factors, recurrence pattern and stage at presentation [J].
Balaji, KC ;
McGuire, M ;
Grotas, J ;
Grimaldi, G ;
Russo, P .
JOURNAL OF UROLOGY, 1999, 162 (05) :1603-1606
[6]
RISK OF LOCAL URETHRAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER-CANCER [J].
BEAHRS, JR ;
FLEMING, TR ;
ZINCKE, H .
JOURNAL OF UROLOGY, 1984, 131 (02) :264-266
[7]
Bierkens AF, 1996, EUR UROL, V30, P363
[8]
BRASLIS KG, 1994, UROL CLIN N AM, V21, P653
[9]
Surveillance of upper urinary tract transitional cell carcinoma: The role of ureteroscopy, retrograde pyelography, cytology and urinalysis [J].
Chen, GL ;
El-Gabry, EA ;
Bagley, DH .
JOURNAL OF UROLOGY, 2000, 164 (06) :1901-1904
[10]
Percutaneous transrenal electro-incision of ureterointestinal anastomotic strictures: Long-term results and comparison of fluoroscopic and endoscopic guidance [J].
Cornud, F ;
Lefebvre, JF ;
Chretien, Y ;
Helenon, O ;
Casanova, JM ;
Moreau, JF .
JOURNAL OF UROLOGY, 1996, 155 (05) :1575-1578